Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities. The acquisition gives Scipher new data management and analytics capabilities to enable a more granular and real-time understanding of patients’ treatment pathway. CrossBridge’s SaaS value-based care platform bridges gaps between patients, providers, payers, and improves health outcomes and lowers the cost of care for autoimmune disease patients.
Read the full article: Scipher Medicine Acquires CrossBridge //
Source: https://www.businesswire.com/news/home/20230110005763/en/Scipher-Medicine-Acquires-CrossBridge-and-its-SaaS-Platform-to-Collect-and-Map-Patient-Molecular-Outcomes-and-Claims-Data-in-Real-Time